Immunotherapy plus chemotherapy showed superior clinical benefit to chemotherapy alone in advanced NSCLC patients after progression on osimertinib

por Long, Yaping, Xiong, Qi, Song, Qi, Li, Yao, Li, Xiaoyan, Qin, Boyu, Huang, Ziwei, Hu, Yi, Yang, Bo
Publicado 2021

Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study

por Long, Yaping, Yang, Wenyu, Bai, Yibing, Tao, Haitao, Zhang, Fan, Wang, Lijie, Yang, Bo, Huang, Di, Han, Xiao, Hu, Yi
Publicado 2023

Efficacy and safety of pembrolizumab versus sintilimab treatment in patients with advanced squamous lung cancer: A real-world study in China

por Yang, Wenyu, Li, Tao, Bai, Yibing, Long, Yaping, Gao, Ming, Wang, Ting, Jing, Fangfang, Zhang, Fan, Tao, Haitao, Ma, Junxun, Wang, Lijie, Hu, Yi
Publicado 2023

Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma

por Long, Yaping, Gao, Zihe, Hu, Xiao, Xiang, Feng, Wu, Zhaozhen, Zhang, Jiahui, Han, Xiao, Yin, Liyong, Qin, Junfang, Lan, Lan, Yin, Fuzai, Wang, Yue
Publicado 2018

Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study

por Cui, Pengfei, Liu, Zhefeng, Wang, Guoqiang, Ma, Junxun, Qian, Yuanyu, Zhang, Fan, Han, Chun, Long, Yaping, Li, Ye, Zheng, Xuan, Sun, Danyang, Zhang, Jing, Cai, Shangli, Jiao, Shunchang, Hu, Yi
Publicado 2018